Pharmacie du progrès: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Pharmacie du progrès
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€11,209
2024 · €45,280-€34,071
Equity
€340,467
2024 · €345,258-€4,791
Cash
€103,359
2024 · €103,862-€502
Balance sheet total
€553,649
2024 · €568,429-€14,780
Largest movements
Assets
- Tangible fixed assets -€32,445
down €32,445 (-16.6%), from €195,854 to €163,409
of which Furniture and vehicles: -€16,931
- Current investments +€26,000
new in 2025: €26,000
- Receivables within one year -€5,982
down €5,982 (-4.3%), from €140,645 to €134,663
of which Trade receivables: -€18,050
Equity and liabilities
- Debts after one year -€16,335
down €16,335 (-51.8%), from €31,550 to €15,215
- Other debts +€16,000
new in 2025: €16,000
- Current portion of long-term debt -€12,795
down €12,795 (-43.9%), from €29,131 to €16,335
- Revaluation surpluses -€10,000
down €10,000 (-10.0%), from €100,000 to €90,000
- Short-term financial debts +€7,607
new in 2025: €7,607
Income statement
- Gross operating margin -€31,219
down €31,219 (-15.1%), from €206,453 to €175,234
- Staff costs +€27,182
up €27,182 (+32.1%), from €84,795 to €111,977
- Taxes -€11,833
down €11,833 (-51.5%), from €22,995 to €11,162
- Depreciation -€11,722
down €11,722 (-26.5%), from €44,168 to €32,445
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€45,280
Gross operating margin
-€31,219
Staff costs
-€27,182
Depreciation
+€11,722
Write-downs
+€304
Other operating charges
-€1,157
Financial income
+€275
Financial charges
+€1,353
Taxes
+€11,833
Result 2025
€11,209
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€63,022
Investment
-€26,000
Financing
-€37,524
Cash 2024
€103,862
From operations (derived)
+€63,022
Net result for the year
+€11,209
Depreciation
+€32,445
Stocks and contracts
-€85
Receivables within one year
+€5,982
Deferred charges and accrued income
+€1,935
Trade debts
-€6,455
Tax, wage and social debts
+€1,996
Other debts
+€16,000
Accrued charges and deferred income
-€6
Investment (derived)
-€26,000
Current investments
-€26,000
Financing
-€37,524
Debts after one year
-€16,335
Current portion of long-term debt
-€12,795
Short-term financial debts
+€7,607
Contributions, distributions and other
-€16,000
Cash 2025
€103,359
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €568,429 | €553,649 | -€14,780 | -2.6% |
| Fixed assets | 21/28 | €196,499 | €164,054 | -€32,445 | -16.5% |
| Tangible fixed assets | 22/27 | €195,854 | €163,409 | -€32,445 | -16.6% |
| Land and buildings | 22 | €128,508 | €118,508 | -€10,000 | -7.8% |
| Plant, machinery and equipment | 23 | €33,531 | €28,016 | -€5,514 | -16.4% |
| Furniture and vehicles | 24 | €33,816 | €16,885 | -€16,931 | -50.1% |
| Financial fixed assets | 28 | €645 | €645 | = | 0.0% |
| Current assets | 29/58 | €371,930 | €389,595 | +€17,665 | +4.7% |
| Stocks and contracts in progress | 3 | €116,965 | €117,050 | +€85 | +0.1% |
| Stocks | 30/36 | €116,965 | €117,050 | +€85 | +0.1% |
| Amounts receivable within one year | 40/41 | €140,645 | €134,663 | -€5,982 | -4.3% |
| Trade receivables | 40 | €106,186 | €88,136 | -€18,050 | -17.0% |
| Other amounts receivable | 41 | €34,459 | €46,527 | +€12,068 | +35.0% |
| Current investments | 50/53 | - | €26,000 | +€26,000 | |
| Cash at bank and in hand | 54/58 | €103,862 | €103,359 | -€502 | -0.5% |
| Deferred charges and accrued income | 490/1 | €10,459 | €8,524 | -€1,935 | -18.5% |
| Total equity and liabilities | 10/49 | €568,429 | €553,649 | -€14,780 | -2.6% |
| Equity | 10/15 | €345,258 | €340,467 | -€4,791 | -1.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Revaluation surpluses | 12 | €100,000 | €90,000 | -€10,000 | -10.0% |
| Reserves | 13 | €226,658 | €231,867 | +€5,209 | +2.3% |
| Non-distributable reserves | 130/1 | €5,446 | €5,446 | = | 0.0% |
| Reserves not available under the articles | 1311 | €5,446 | €5,446 | = | 0.0% |
| Distributable reserves | 133 | €221,212 | €226,421 | +€5,209 | +2.4% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €223,171 | €213,182 | -€9,989 | -4.5% |
| Amounts payable after more than one year | 17 | €31,550 | €15,215 | -€16,335 | -51.8% |
| Financial debts | 170/4 | €31,550 | €15,215 | -€16,335 | -51.8% |
| Amounts payable within one year | 42/48 | €191,615 | €197,967 | +€6,352 | +3.3% |
| Current portion of amounts payable after more than one year | 42 | €29,131 | €16,335 | -€12,795 | -43.9% |
| Financial debts | 43 | - | €7,607 | +€7,607 | |
| Credit institutions | 430/8 | - | €7,607 | +€7,607 | |
| Trade debts | 44 | €128,037 | €121,582 | -€6,455 | -5.0% |
| Suppliers | 440/4 | €128,037 | €121,582 | -€6,455 | -5.0% |
| Taxes, remuneration and social security | 45 | €34,447 | €36,443 | +€1,996 | +5.8% |
| Taxes | 450/3 | €17,410 | €18,397 | +€987 | +5.7% |
| Remuneration and social security | 454/9 | €17,036 | €18,046 | +€1,010 | +5.9% |
| Other amounts payable | 47/48 | - | €16,000 | +€16,000 | |
| Accrued charges and deferred income | 492/3 | €6 | €0 | -€6 | -100.0% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €84,795 | €111,977 | +€27,182 | +32.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €44,168 | €32,445 | -€11,722 | -26.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €306 | €2 | -€304 | -99.4% |
| Other operating charges | 640/8 | €3,145 | €4,302 | +€1,157 | +36.8% |
| Gross operating margin | 9900 | €206,453 | €175,234 | -€31,219 | -15.1% |
| Operating profit (loss) | 9901 | €74,040 | €26,508 | -€47,532 | -64.2% |
| Financial income | 75/76B | €409 | €684 | +€275 | +67.3% |
| Recurring financial income | 75 | €409 | €684 | +€275 | +67.3% |
| Financial charges | 65/66B | €6,174 | €4,821 | -€1,353 | -21.9% |
| Recurring financial charges | 65 | €6,174 | €4,821 | -€1,353 | -21.9% |
| Profit (loss) for the period before taxes | 9903 | €68,275 | €22,371 | -€45,904 | -67.2% |
| Income taxes | 67/77 | €22,995 | €11,162 | -€11,833 | -51.5% |
| Profit (loss) for the period | 9904 | €45,280 | €11,209 | -€34,071 | -75.2% |
| Profit (loss) for the period to be appropriated | 9905 | €45,280 | €11,209 | -€34,071 | -75.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.